The Current Ratio as of December 2024 (TTM) for Panbela Therapeutics, Inc. (PBLA) is 0.26

According to Panbela Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.26. This represents a change of 42.41% compared to the average of 0.18 of the last 4 quarters.

Panbela Therapeutics, Inc. (PBLA) Historical Current Ratio (quarterly & annually)

How has PBLA Current Ratio performed in the past?

The mean historical Current Ratio of Panbela Therapeutics, Inc. over the last ten years is 1.74. The current 0.26 Current Ratio has changed 1.38% with respect to the historical average. Over the past ten years (40 quarters), PBLA's Current Ratio was at its highest in in the September 2021 quarter at 11.01. The Current Ratio was at its lowest in in the June 2024 quarter at 0.05.

Panbela Therapeutics, Inc. (PBLA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Panbela Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Panbela Therapeutics, Inc. (PBLA) Average Current Ratio

How has PBLA Current Ratio performed in the past?

The current Current Ratio of Panbela Therapeutics, Inc. (PBLA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Panbela Therapeutics, Inc. (PBLA) Current Ratio vs. Peers

How is PBLA’s Current Ratio compared to its peers?

Panbela Therapeutics, Inc.’s Current Ratio is less than ZyVersa Therapeutics, Inc. (33.83), less than Sonnet BioTherapeutics Holdings, Inc. (0.66), less than Revelation Biosciences, Inc. (1.64), less than Navidea Biopharmaceuticals, Inc. (0.56), less than Altamira Therapeutics Ltd. (1.38), less than Palisade Bio, Inc. (3.31), less than Virax Biolabs Group Limited (25.94), less than Quoin Pharmaceuticals, Ltd. (3.02), less than Unicycive Therapeutics, Inc. (3.61), less than Cardio Diagnostics Holdings, Inc. (8.51), less than PaxMedica, Inc. Common Stock (0.38), greater than Blue Water Vaccines, Inc. (0.06), less than Hillstream BioPharma, Inc. (2.25), less than Kiora Pharmaceuticals, Inc. (8.97),

Build a custom stock screener for Panbela Therapeutics, Inc. (PBLA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Panbela Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Panbela Therapeutics, Inc. (PBLA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Panbela Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.